Wikidata

(Q61921635)

English

A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

clinical trial

In more languages

Statements

title
The Official Title is A Multi-center, Randomized, Parallel-group, Double-blind, Placebo Controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma. (English)
0 references
sponsor
Celgene
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
France
0 references
Germany
0 references
Greece
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Ukraine
0 references
United Kingdom
0 references
main subject
cytogenetics
0 references
(RS)-lenalidomide
0 references
start time
1 January 2003
0 references
end time
1 November 2005
0 references
number of participants
351
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61921635&oldid=2109301959"